Becton, Dickinson and Company (BDX) News Today

Chevy Chase Trust Holdings LLC reduced its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 2.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 172,665 shares of the medical instrument

Raymond James Financial Services Advisors Inc. trimmed its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 8.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 142,997 shares of the medical in

Raymond James & Associates cut its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 0.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 600,248 shares of the medical instruments supplier's stock after selling

Sumitomo Mitsui Trust Holdings Inc. decreased its stake in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 7.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 657,516

Swedbank AB boosted its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 2.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,109 shares of the medical instruments supplier's

Wealth Enhancement Advisory Services LLC decreased its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 5.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 45,090 shares of the medical instruments supplier's s

Addenda Capital Inc. lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 17.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 35,363 shares of the medical instruments supplier's stock after a

M&G Plc lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 0.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 709,259 shares of the medical instruments supplier'

D.B. Root & Company LLC decreased its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 52.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,213 shares of the medical instruments supplier's stock after sell

Shares of Becton, Dickinson and Company (NYSE:BDX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven h

OLD National Bancorp IN increased its stake in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 58.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,891 shares of the medical instruments supplier

StockNews.com upgraded shares of Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research note on Thursday.

Cetera Investment Advisers increased its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 380.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,923 shares of the medical instruments

DekaBank Deutsche Girozentrale cut its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 1.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 323,220 shares of the medical instrument

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) announced its earnings results on Thursday. The medical instruments supplier reported $3.50 earnings per share for the quarter, topping analysts' consensus estimates of $3.31 by $0.19. The firm had revenue of $4.99 billion during the quarter, compared to analyst estimates of $5.08 billion. Becton, Dickinson and Company had a net margin of 6.76% and a return on equity of 13.90%. The company's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period in the prior year, the business earned $2.96 EPS.

Plato Investment Management Ltd boosted its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 908.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,945 shares of the medical instru

Raymond James dropped their target price on shares of Becton, Dickinson and Company from $275.00 to $270.00 and set an "outperform" rating for the company in a research report on Friday.

Lbp Am Sa raised its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 159.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,544 shares of the medical instruments supplier's sto

Becton, Dickinson and Company (NYSE:BDX) Shares Gap Down to $241.06

Becton, Dickinson and Company (NYSE:BDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 13.050-13.150 for the period, compared to the consensus estimate of 13.040. The company also issued revenue guidance of $20.1 billionillion-$20.2 billionillion, compared to the consensus estimate of $20.2 billionillion.

California State Teachers Retirement System raised its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 0.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 474,606 shares of the med

Public Employees Retirement System of Ohio cut its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 6.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,239 shares o

Bellevue Group AG boosted its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 7.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 415,700 shares of the medical instruments supplier's st

Quadrature Capital Ltd lowered its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 75.1% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,028 shares of the medical instruments supplier's stock after selling 54,318

Toronto Dominion Bank increased its stake in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 1.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 173,476 shares of the medical instru

Stifel Nicolaus boosted their price target on Becton, Dickinson and Company from $270.00 to $280.00 and gave the stock a "buy" rating in a research report on Friday.

National Bank of Canada FI lowered its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 59.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 126,554 shares of the medical instruments supplier's stock

Becton, Dickinson and Company (NYSE:BDX) will be releasing earnings before the market opens on Thursday, August 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=560284)